Tag Archives: Long acting Beta Antagonist

Antibody treatment – Omalizumab

Omalizumab is an Anti IgE monoclonal antibody. It is licensed for use only in adults and children over 6 yrs. It may be considered as therapy only if you: Have impaired lung function. Have frequent asthma attacks and are symptomatic. Are taking high-dose steroid inhalers and Long-acting beta receptor antagonists which last for up to 12 hours. […]